SCHEMBL23029802

SCHEMBL23029802

Cc1cc(C(=O)N(C)C)cn2c(C)cnc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 1/20 0.34
RIPK2 O43353 4/20 0.34
KMT2A Q03164 1/20 0.33
SRC P12931 1/20 0.32
GAA P10253 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
PABPC1 P11940 1/20 0.32
CASP1 P29466 1/20 0.32
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MKNK1 Q9BUB5 2/20 0.32
MKNK2 Q9HBH9 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
LMNA P02545 1/20 0.31
RAD52 P43351 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24857457 0.83 LMNA (0.35) FYNRIPK2KMT2AKEAP1NFE2L2
SCHEMBL25149773 0.79 ATM (0.41) KMT2AGAAALDH1A1KDM4ELMNA
SCHEMBL23029808 0.73 L3MBTL1 (0.51) KMT2AGAAALDH1A1HPGDKDM4E
SCHEMBL25948856 0.71 NOS3 (0.34)
SCHEMBL29229603 0.71 HCAR2 (0.35) ALDH1A1KDM4EHSD17B10SMN1; SMN2EGLN1
SCHEMBL23030036 0.71 TGFBR1 (0.43) GAAALDH1A1HPGDKDM4EPABPC1
SCHEMBL19781524 0.68 L3MBTL1 (0.49) KDM4EPABPC1HSD17B10RAD52
SCHEMBL23029845 0.68 PDE10A (0.32)
SCHEMBL25149523 0.68 PIK3CD (0.42) KMT2AALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL27398995 0.68 RXFP1 (0.40) ALDH1A1KDM4EHSD17B10EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002414-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) 2023-01-05 US disclosed
EP-4019521-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF Blueray Therapeutics (Shanghai) Co., Ltd (CN) 2022-06-29 EP disclosed
WO-2021032004-A9 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF 上海青煜医药科技有限公司 2021-03-25 WO disclosed
WO-2021032004-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF 上海青煜医药科技有限公司 2021-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002414-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF EZH2, EED, SUZ12 FYN 1008/4885RIPK2 2160/4885KMT2A 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.